{"title":"非洲加巴喷丁类药物警戒","authors":"FP Omullo","doi":"10.1136/bmj.r1355","DOIUrl":null,"url":null,"abstract":"Yuen and colleagues present UK data on the temporal association between gabapentinoid use and self-harm.1 Extrapolating these findings to the African population requires a pragmatic approach owing to diverging prescribing practices, regulatory disparities, and healthcare system limitations. Across many African nations, gabapentinoids are frequently prescribed off-label …","PeriodicalId":22388,"journal":{"name":"The BMJ","volume":"46 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Gabapentinoid pharmacovigilance in Africa\",\"authors\":\"FP Omullo\",\"doi\":\"10.1136/bmj.r1355\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Yuen and colleagues present UK data on the temporal association between gabapentinoid use and self-harm.1 Extrapolating these findings to the African population requires a pragmatic approach owing to diverging prescribing practices, regulatory disparities, and healthcare system limitations. Across many African nations, gabapentinoids are frequently prescribed off-label …\",\"PeriodicalId\":22388,\"journal\":{\"name\":\"The BMJ\",\"volume\":\"46 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The BMJ\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/bmj.r1355\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The BMJ","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmj.r1355","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Yuen and colleagues present UK data on the temporal association between gabapentinoid use and self-harm.1 Extrapolating these findings to the African population requires a pragmatic approach owing to diverging prescribing practices, regulatory disparities, and healthcare system limitations. Across many African nations, gabapentinoids are frequently prescribed off-label …
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
